Skip to main content

Lannett Company, Inc. (LCI)

NYSE: LCI · IEX Real-Time Price · USD
2.04 -0.02 (-0.97%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap87.73M
Revenue (ttm)453.82M
Net Income (ttm)-379.32M
Shares Out43.00M
EPS (ttm)-9.58
PE Ration/a
Forward PE16.39
Dividendn/a
Ex-Dividend Daten/a
Volume422,948
Open2.09
Previous Close2.06
Day's Range2.00 - 2.12
52-Week Range1.53 - 10.70
Beta1.03
AnalystsHold
Price Target5.00 (+145.1%)
Earnings DateNov 3, 2021

About LCI

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular,...

IndustryPharmaceuticals
Founded1942
CEOTimothy Crew
Employees810
Stock ExchangeNYSE
Ticker SymbolLCI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for LCI stock is "Hold." The 12-month stock price forecast is 5.00, which is an increase of 145.10% from the latest price.

Price Target
$5.00
(145.10% upside)
Analyst Consensus: Hold

News

Lannett (LCI) Reports Q1 Loss, Tops Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of -8.00% and 2.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down Full-year Guidance

PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 first quarter ended September 30, 2021.  "For the quarter, solid sales o...

1 month ago - PRNewsWire

Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3

PHILADELPHIA, Oct. 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 first quarter on Wednesday, November 3, 2021, afte...

1 month ago - PRNewsWire

Earnings Preview: Lannett (LCI) Q1 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

New Strong Sell Stocks for August 30th

WKHS, EGLX, LCI, TTI, and PAA have been added to the Zacks Rank #5 (Strong Sell) List on August 30, 2021

Other symbols:EGLXPAATTIWKHS
3 months ago - Zacks Investment Research

Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension

PHILADELPHIA, Aug. 30, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL, an internally deve...

3 months ago - PRNewsWire

Why Lannett Stock Is Plunging After Q4 Earnings Report?

Lannett Company Inc (NYSE: LCI) reported Q4 FY21 sales of $106 million, missing the consensus of $110.63 million. Sales decreased 23.1% Y/Y as Lannett's several key products faced a highly competitive p...

3 months ago - Benzinga

Lannett Announces Fiscal 2021 Fourth-Quarter, Full-Year Financial Results

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021.  "With the recently s...

3 months ago - PRNewsWire

Lannett To Report Fiscal 2021 Fourth-quarter, Full-year Financial Results, Host Conference Call On Wednesday, August 25

PHILADELPHIA, Aug. 18, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 fourth quarter and full year on Wednesday, August ...

3 months ago - PRNewsWire

LCI Industries: Q2 Earnings Insights

Shares of LCI Indus (NYSE:LCII) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 396.30% year over year to $2.68, which missed the estimate of $2.71.

4 months ago - Benzinga

Lannett Stock Jumps On US Commercialization Pact For Spiriva Handihaler

Lannett Company Inc (NYSE: LCI) enters into an exclusive U.S. commercialization agreement for a generic Spiriva Handihaler (Tiotropium Bromide inhalation powder) with Respirent Pharmaceuticals Co Ltd.  ...

4 months ago - Benzinga

LANNETT expands respiratory pipeline, signs exclusive distribution agreement for generic SPIRIVA® handihaler®

PHILADELPHIA, July 29, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. commercialization agreement for a therapeutically equivalent gene...

4 months ago - PRNewsWire

Lannett Launches Fluvastatin Sodium ER Tablets

PHILADELPHIA, July 12, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it recently began marketing Fluvastatin Sodium Extended-release Tablets, 80 mg, a partnered product. To...

4 months ago - PRNewsWire

Lannett (LCI) Soars 10.1%: Is Further Upside Left in the Stock?

Lannett (LCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

6 months ago - Zacks Investment Research

Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing

PHILADELPHIA, June 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the U.S. Food and Drug Administration (FDA) has accepted the Abbreviated New Drug Application (ANDA) for Flut...

6 months ago - PRNewsWire

Why Lannett Flopped on Friday

The generic-drug maker gets ejected from a top small-cap stock index.

6 months ago - The Motley Fool

Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600

NEW YORK, May 27, 2021 /PRNewswire/ -- Organon & Co. (NYSE: OGN) will be added to the S&P 500 prior to the open of trading on Thursday, June 3, replacing HollyFrontier, which will be removed from the S&...

Other symbols:MRKOGNSPGI
6 months ago - PRNewsWire

Lannett (LCI) Beats Q3 Earnings Estimates

Lannett (LCI) delivered earnings and revenue surprises of 140.00% and -2.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Lannett Announces Fiscal 2021 Third-Quarter Financial Results

PHILADELPHIA, May 5, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 third quarter ended March 31, 2021.  "In recent months, we have significa...

7 months ago - PRNewsWire

Earnings Preview: Lannett (LCI) Q3 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Lannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 5

PHILADELPHIA, April 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 third quarter on Wednesday, May 5, 2021, after th...

7 months ago - PRNewsWire

Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan Facility

PHILADELPHIA, April 22, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the closing of the $350 million aggregate principal amount of 7.750% senior secured notes due 2026 (the "No...

7 months ago - PRNewsWire

Lannett Announces Pricing Of $350 Million Senior Secured Notes Due 2026

PHILADELPHIA, April 9, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company" or "Lannett") today announced the pricing of the $350 million aggregate principal amount of 7.75% senior secu...

8 months ago - PRNewsWire

Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026

PHILADELPHIA, April 6, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company") today announced that it intends to offer, subject to market conditions and other factors, $350 million aggre...

8 months ago - PRNewsWire

Lannett Submits ANDA For Generic ADVAIR DISKUS®

PHILADELPHIA, April 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the submission of an Abbreviated New Drug Application (ANDA) for Fluticasone propionate and Salmeterol inhal...

8 months ago - PRNewsWire